Insider Selling: Outset Medical, Inc. (NASDAQ:OM) SVP Sells 23,221 Shares of Stock

Outset Medical, Inc. (NASDAQ:OM) SVP Marc Nash sold 23,221 shares of the company’s stock in a transaction that occurred on Tuesday, January 21st. The stock was sold at an average price of $0.80, for a total value of $18,576.80. Following the completion of the sale, the senior vice president now owns 204,968 shares of the company’s stock, valued at $163,974.40. This trade represents a 10.18 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Marc Nash also recently made the following trade(s):

• On Monday, January 13th, Marc Nash sold 15,011 shares of Outset Medical stock. The stock was sold at an average price of $0.81, for a total value of $12,158.91.
• On Tuesday, January 7th, Marc Nash sold 720 shares of Outset Medical stock. The stock was sold at an average price of $1.29, for a total transaction of $928.80.
• On Friday, November 15th, Marc Nash sold 1,375 shares of Outset Medical stock. The shares were sold at an average price of $0.80, for a total transaction of $1,100.00.

Outset Medical Stock Down 3.3 %

OM stock opened at $0.78 on Thursday. Outset Medical, Inc. has a one year low of $0.44 and a one year high of $5.22. The firm has a 50-day moving average of $1.01 and a two-hundred day moving average of $1.28. The company has a quick ratio of 5.04, a current ratio of 6.49 and a debt-to-equity ratio of 4.12.

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada reiterated a “sector perform” rating and set a $3.00 price objective on shares of Outset Medical in a research report on Tuesday, January 7th.

Institutional Investors Weigh In On Outset Medical

A number of large investors have recently made changes to their positions in the company. Vanguard Personalized Indexing Management LLC acquired a new stake in Outset Medical during the 2nd quarter valued at $49,000. Huntington National Bank boosted its position in shares of Outset Medical by 46.2% in the third quarter. Huntington National Bank now owns 63,306 shares of the company’s stock worth $43,000 after buying an additional 20,000 shares during the period. National Bank of Canada FI grew its holdings in shares of Outset Medical by 79.2% during the third quarter. National Bank of Canada FI now owns 52,407 shares of the company’s stock valued at $35,000 after buying an additional 23,164 shares in the last quarter. Squarepoint Ops LLC grew its holdings in shares of Outset Medical by 74.1% during the second quarter. Squarepoint Ops LLC now owns 80,300 shares of the company’s stock valued at $309,000 after buying an additional 34,187 shares in the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. acquired a new position in Outset Medical during the second quarter valued at $259,000.

About Outset Medical

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.